• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受生物治疗患者的护理管理

Nursing management of patients receiving biological therapy.

作者信息

Sandstrom S K

机构信息

Experimental Therapeutics Program, Cleveland Clinic Foundation, OH 44195, USA.

出版信息

Semin Oncol Nurs. 1996 May;12(2):152-62. doi: 10.1016/s0749-2081(96)80009-x.

DOI:10.1016/s0749-2081(96)80009-x
PMID:8727802
Abstract

OBJECTIVE

To provide an overview of the most common toxic effects associated with biotherapy and strategies for effective patient management, predominantly in the outpatient setting.

DATA SOURCES

Review articles and book chapters related to nursing care of patients receiving biotherapy.

CONCLUSIONS

Biological response modifiers can produce several toxic effects that may have a significant impact on the patient's quality of life. Additionally, biotherapy is being delivered more frequently in the ambulatory and home care settings.

IMPLICATIONS FOR NURSING PRACTICE

As the role of biotherapy expands in the treatment of cancer, oncology nurses must be attuned to the special needs of patients receiving this therapy. Nurses must be knowledgeable of not only symptom management but reimbursement and managed care issues as well.

摘要

目的

概述生物治疗最常见的毒性作用以及有效管理患者的策略,主要针对门诊环境。

数据来源

与接受生物治疗患者的护理相关的综述文章和书籍章节。

结论

生物反应调节剂可产生多种毒性作用,可能对患者的生活质量产生重大影响。此外,生物治疗在门诊和家庭护理环境中的应用越来越频繁。

对护理实践的启示

随着生物治疗在癌症治疗中的作用不断扩大,肿瘤护士必须关注接受该治疗患者的特殊需求。护士不仅要了解症状管理,还要了解报销和管理式医疗问题。

相似文献

1
Nursing management of patients receiving biological therapy.接受生物治疗患者的护理管理
Semin Oncol Nurs. 1996 May;12(2):152-62. doi: 10.1016/s0749-2081(96)80009-x.
2
Future projections in biotherapy.生物疗法的未来预测。
Semin Oncol Nurs. 1996 May;12(2):163-71. doi: 10.1016/s0749-2081(96)80010-6.
3
Biotherapy and the oncology nurse.生物疗法与肿瘤学护士。
Semin Oncol Nurs. 1996 May;12(2):82-8. doi: 10.1016/s0749-2081(96)80002-7.
4
Symptom assessment and management of outpatients receiving biotherapy: the application of a symptom report form.接受生物疗法的门诊患者的症状评估与管理:症状报告表的应用
Semin Oncol Nurs. 1992 Nov;8(4 Suppl 1):23-8. doi: 10.1016/0749-2081(92)90051-4.
5
Physical symptoms of combination biotherapy: a quality-of-life issue.
Oncol Nurs Forum. 1991 Jan-Feb;18(1 Suppl):25-30.
6
Coping with biotherapy: physiological and psychosocial concerns.应对生物疗法:生理和心理社会方面的问题
Oncol Nurs Forum. 1991 Jan-Feb;18(1 Suppl):19-23.
7
Nursing considerations for patients receiving biological response modifiers.接受生物反应调节剂治疗患者的护理注意事项。
Semin Oncol Nurs. 1993 Aug;9(3 Suppl 1):32-5.
8
Overview of biotherapy and nursing considerations.生物疗法概述及护理注意事项
J Intraven Nurs. 1998 Nov-Dec;21(6):367-73.
9
Biotherapy: recent advances and nursing implications.
Nurs Clin North Am. 1990 Jun;25(2):291-308.
10
Monoclonal antibodies: innovations in diagnosis and therapy.单克隆抗体:诊断与治疗的创新
Semin Oncol Nurs. 1996 May;12(2):130-41. doi: 10.1016/s0749-2081(96)80007-6.

引用本文的文献

1
Tumor Necrosis Alpha (TNF-α) Antagonists Used in Chronic Inflammatory Rheumatic Diseases: Risks and their Minimization Measures.肿瘤坏死因子-α(TNF-α)拮抗剂在慢性炎症性风湿病中的应用:风险及其最小化措施。
Curr Drug Saf. 2024;19(4):431-443. doi: 10.2174/0115748863274863231222023853.